VANCOUVER, BRITISH COLUMBIA–(Marketwired – Dec. 1, 2016) – Reliq Health Technologies Inc. (TSX VENTURE:RHT)(OTCQB:RQHTF) (“Reliq” or the “Company“), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it has begun enrolling patients for the pilot of its remote patient monitoring and secure communication solution with The Feldman Institute in Baton Rouge, Louisiana. The pilot will evaluate the use of Reliq Health’s technology with patients who have been discharged home after interventional pain management surgery, or have returned to their homes between treatments at The Feldman Institute.
“We are very pleased to be enrolling patients and launching our pilot of the Reliq Health platform with The Feldman Institute,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “Our virtual care solution allows patients to receive high quality follow up care from the comfort of their own homes. Patients can communicate with their care team at The Feldman Institute using Reliq’s cloud-based secure messaging, videoconferencing and virtual visits. The Reliq Health cloud provides access to patient education materials and instructional videos, empowering patients and their families to actively participate in their own care at home. We look forward to working with The Feldman Institute to improve treatment outcomes, reduce the risk of post-surgical complications and increase access to specialized pain management care for their chronic pain patients.”
The Feldman Institute is committed to providing patients with compassionate, accessible healthcare. The pilot is designed to validate the use of Reliq Health’s virtual care solution to help patients better manage and document their symptoms in the home, and facilitate secure and timely communication between patients and family members and their care team at The Feldman Institute. Many of the patients treated at The Feldman Institute travel great distances to receive cutting edge pain management surgery and other treatments. Reliq Health’s remote patient monitoring and secure communication platform will allow these patients to continue to receive high quality care even after they return home.
The Feldman Institute’s mission is to relieve chronic pain and restore health, comfort and quality of life in a collaborative and compassionate environment. The clinical team is committed to eliminating pain through research and innovation while working closely with each patient to find their appropriate level of care. The Feldman Institute is dedicated to helping its patients through a comprehensive program of interventional pain management. The team specializes in performing minimally invasive, outpatient, and Endoscopic Discectomy procedures to address problems such as herniated discs, bulging discs, or ruptured discs. These advanced procedures are alternatives to open back and neck surgery and do not require general anesthesia. Patients undergoing these procedures experience far less trauma and a much shorter recovery time. The diagnosis and treatment techniques offered at the Feldman Institute represent the leading edge of recent medical advances.
ON BEHALF OF THE BOARD
Dr. Lisa Crossley, CEO and Director
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements.”
We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.
Reliq Health Technologies Inc. (the “Company“) does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company’s historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.
